scholarly journals Role of Upper and Lower Respiratory Tract Immunity in Resistance to Mycoplasma Respiratory Disease

2002 ◽  
Vol 186 (2) ◽  
pp. 290-294 ◽  
Author(s):  
Lisa M. Hodge ◽  
Jerry W. Simecka
Keyword(s):  
Respiratory Tract ◽  
Respiratory Disease ◽  
Lower Respiratory Tract

ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION

PEDIATRICS ◽  
1965 ◽  
Vol 36 (1) ◽  
pp. 21-39
Author(s):  
Robert M. Chanock ◽  
Robert H. Parrott
Keyword(s):  
Respiratory Tract ◽  
Respiratory Disease ◽  
Lower Respiratory Tract ◽  
Pathogenic Bacteria ◽  
Upper Respiratory Tract ◽  
Respiratory Tract Disease ◽  
Acute Respiratory Disease ◽  
Infancy And Childhood ◽  
Tract Disease

DURING the past ten years there has been an exponential increase in our understanding of the etiology and epidemiology of acute respiratory disease. Unfortunately development of the means for control of these illnesses has not kept pace with etiologic or epidemiologic understanding. In this presentation an attempt will he made to summarize the role of a number of viruses and mycoplasmas in acute respiratory disease of infancy and childhood. In addition the ecology of such infections will be discussed, particularly those aspects of infection which have relevance to the problem of immunoprophylaxis. Much of the information to be discussed is derived from studies at the Children's Hospital of D.C. and the Junior Village Welfare Nursery of D.C. In many instances similar findings have been reported from other localities so that the conclusions which can be drawn from the Washington, D.C., studies would appear to have more than local significance. Since the Washington D.C., studies represent the longest continuous inquiry into the nature of acute pediatric respiratory disease primary emphasis will be placed on the interpretation of these findings. Bacteria Although group A beta hemolytic streptococci play an important role in upper respiratory tract disease it would appear that these organisms are relatively unimportant in the more serious types of illness in which lower respiratory tract involvement occurs. The careful studies of Babe, Beem, and co-workers indicate that pathogenic bacteria are not important primary etiologic agents in lower respiratory tract disease of infancy and childhood. For this reason major emphasis in this presentation will be given to the role of viruses and mycoplasmas in respiratory disease.

scholarly journals The lung microbiota in Korean patients with non-tuberculous mycobacterial pulmonary disease

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sung-Yoon Kang ◽  
Hyojung Kim ◽  
Sungwon Jung ◽  
Sang Min Lee ◽  
Sang Pyo Lee
Keyword(s):  
Principal Component Analysis ◽  
Respiratory Tract ◽  
Pulmonary Disease ◽  
Beta Diversity ◽  
Lower Respiratory Tract ◽  
Principal Component ◽  
Control Group ◽  
Flexible Bronchoscope ◽  
Bronchial Washing

Abstract Background The microbiota of the lower respiratory tract in patients with non-tuberculous mycobacterial pulmonary disease (NTM-PD) has not been fully evaluated. We explored the role of the lung microbiota in NTM-PD by analyzing protected specimen brushing (PSB) and bronchial washing samples from patients with NTM-PD obtained using a flexible bronchoscope. Results Bronchial washing and PSB samples from the NTM-PD group tended to have fewer OTUs and lower Chao1 richness values compared with those from the control group. In both bronchial washing and PSB samples, beta diversity was significantly lower in the NTM-PD group than in the control group (P = 2.25E-6 and P = 4.13E-4, respectively). Principal component analysis showed that the PSBs and bronchial washings exhibited similar patterns within each group but differed between the two groups. The volcano plots indicated differences in several phyla and genera between the two groups. Conclusions The lower respiratory tract of patients with NTM-PD has a unique microbiota distribution that is low in richness/diversity.

scholarly journals Role of the Dermonecrotic Toxin of Bordetella bronchiseptica in the Pathogenesis of Respiratory Disease in Swine

2002 ◽  
Vol 70 (2) ◽  
pp. 481-490 ◽  
Author(s):  
Susan L. Brockmeier ◽  
Karen B. Register ◽  
Tibor Magyar ◽  
Alistair J. Lax ◽  
Gillian D. Pullinger ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Respiratory Disease ◽  
Bordetella Bronchiseptica ◽  
Atrophic Rhinitis ◽  
Upper Respiratory Tract ◽  
Dermonecrotic Toxin ◽  
Etiologic Agents ◽  
Upper Respiratory ◽  
Phosphate Buffered Saline

ABSTRACT Bordetella bronchiseptica is one of the etiologic agents causing atrophic rhinitis and pneumonia in swine. It produces several purported virulence factors, including the dermonecrotic toxin (DNT), which has been implicated in the turbinate atrophy seen in cases of atrophic rhinitis. The purpose of these experiments was to clarify the role of this toxin in respiratory disease by comparing the pathogenicity in swine of two isogenic dnt mutants to their virulent DNT+ parent strains. Two separate experiments were performed, one with each of the mutant-parent pairs. One-week-old cesarean-derived, colostrum-deprived pigs were inoculated intranasally with the parent strain, the dnt mutant strain, or phosphate-buffered saline. Weekly nasal washes were performed to monitor colonization of the nasal cavity, and the pigs were euthanized 4 weeks after inoculation to determine colonization of tissues and to examine the respiratory tract for pathology. There was evidence that colonization of the upper respiratory tract, but not the lower respiratory tract, was slightly greater for the parent strains than for the dnt mutants. Moderate turbinate atrophy and bronchopneumonia were found in most pigs given the parent strains, while there was no turbinate atrophy or pneumonia in pigs challenged with the dnt mutant strains. Therefore, production of DNT by B. bronchiseptica is necessary to produce the lesions of turbinate atrophy and bronchopneumonia in pigs infected with this organism.

scholarly journals The Role of the Immune Response in the Pathogenesis of Bronchiectasis

2018 ◽  
Vol 2018 ◽  
pp. 1-12 ◽  
Author(s):  
Paul T. King
Keyword(s):  
Immune Response ◽  
Inflammatory Response ◽  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Therapeutic Potential ◽  
Small Airways ◽  
Upper Respiratory Tract ◽  
Causative Factors ◽  
Triggering Factor

Bronchiectasis is a prevalent respiratory condition characterised by permanent and abnormal dilation of the lung airways (bronchi). There are a large variety of causative factors that have been identified for bronchiectasis; all of these compromise the function of the immune response to fight infection. A triggering factor may lead to the establishment of chronic infection in the lower respiratory tract. The bacteria responsible for the lower respiratory tract infection are usually found as commensals in the upper respiratory tract microbiome. The consequent inflammatory response to infection is largely responsible for the pathology of this condition. Both innate and adaptive immune responses are activated. The literature has highlighted the central role of neutrophils in the pathogenesis of bronchiectasis. Proteases produced in the lung by the inflammatory response damage the airways and lead to the pathological dilation that is the pathognomonic feature of bronchiectasis. The small airways demonstrate infiltration with lymphoid follicles that may contribute to localised small airway obstruction. Despite aggressive treatment, most patients will have persistent disease. Manipulating the immune response in bronchiectasis may potentially have therapeutic potential.

Sign in / Sign up

Export Citation Format

Share Document